Indications and uses
for the preparation of normal isotonic solution of Sodium chloride as an electrolyte replenisher for the prevention of heat cramps due to excessive perspiration any alternative use as directed by a physician
Sodium Chloride Normal Salt Tablets (1 gram)
- Manufacturer
- Marlex Pharmaceuticals, Inc.
- Effective date
- 2024-10-18
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-06-01 00:27:23
Label at a glance#
ProductNormal Salt
Active ingredientSODIUM CHLORIDE
Label structure8 sections
Dosage and administration
to make isontonic solution of sodium chloride, dissolve one tablet in 120 ml (four ounces) of distilled water and use as directed by a physician if used as an electrolyte replenisher for the prevention of heat cramps due to excessive perspiration take one tablet orally as directed by your physician
Storage and handling
each tablet contains: sodium 394 mg store at room temperature 15°-30°C (59°-86°F) product does not contain any inactive ingredients
Label contents#
Full prescribing information#
Active ingredient (in each tablet)
Sodium Chloride, USP 1.0 gram
Purpose
Electrolyte Replenisher
Uses
- for the preparation of normal isotonic solution of Sodium chloride
- as an electrolyte replenisher for the prevention of heat cramps due to excessive perspiration
- any alternative use as directed by a physician
Warnings
Enter section text here
Do not use
without consulting a physician
Ask a physician before use
if you have a sodium restricted diet due to multiple organ diseases
Stop use and ask a physician
If symptoms of heat cramps continue for more than 24 hours
If pregnant or breast-feeding
ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away
Directions
- to make isontonic solution of sodium chloride, dissolve one tablet in 120 ml (four ounces) of distilled water and use as directed by a physician
- if used as an electrolyte replenisher for the prevention of heat cramps due to excessive perspiration take one tablet orally as
directed by your physician
Other information
- each tablet contains: sodium 394 mg
- store at room temperature 15°-30°C (59°-86°F)
- product does not contain any inactive ingredients
INACTIVE INGREDIENTS
NONE
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
10135-0783-01 - 100 Count
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 10135-783-01 | 2025-07-29 | C162847 | 48780-1 | 3b156c62-30c5-fb37-e063-e6dba90a4e07 | Sodium Chloride Normal Salt Tablets (1 gram) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10135-783-01 | Normal Salt | 100 in 1 BOTTLE | TABLET | 100 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 10135-783-01 | EA - Each | 10135-783 | ad6ddd9a-7487-4be7-b7e6-0261721012aa | 1 | 2023-12-05 |
Products#
Every source-derived product name is available through these pages.
- Normal Salt
- Sodium Chloride
- WATER
- CHLORIDE ION
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 10135-783 | 10135-783-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 24cc8630-e3fa-c4fa-e063-6394a90abcba | 086435d8-fa6b-691e-e063-6294a90a4abc | 2024-10-18 | Warnings | 24cc8630-e3fa-c4fa-e063-6394a90abcba 086435d8-fa6b-691e-e063-6294a90a4abc |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.